News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,705 Results
Type
Article (86949)
Company Profile (704)
Press Release (766051)
Multimedia
Podcasts (150)
Webinars (19)
Section
Business (232851)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91129)
Employer Resources (199)
FDA (18205)
Job Trends (17369)
News (396918)
Policy (39830)
Tag
Academia (3002)
Academic (2)
Accelerated approval (13)
Adcomms (33)
Allergies (109)
Alliances (56975)
ALS (122)
Alzheimer's disease (1593)
Antibody-drug conjugate (ADC) (192)
Approvals (18155)
Artificial intelligence (405)
Autoimmune disease (38)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (102)
Brain cancer (41)
Breast cancer (400)
Cancer (3170)
Cardiovascular disease (253)
Career advice (3542)
Career pathing (34)
CAR-T (212)
CDC (42)
Cell therapy (585)
Cervical cancer (25)
Clinical research (74422)
Collaboration (1137)
Company closure (3)
Compensation (732)
Complete response letters (37)
COVID-19 (2911)
CRISPR (69)
C-suite (379)
Cystic fibrosis (124)
Data (3182)
Decentralized trials (2)
Denatured (53)
Depression (81)
Diabetes (383)
Diagnostics (6988)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (190)
Drug pricing (154)
Drug shortages (36)
Duchenne muscular dystrophy (154)
Earnings (97666)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131572)
Executive appointments (920)
FDA (20022)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1030)
Gene editing (151)
Generative AI (41)
Gene therapy (455)
GLP-1 (941)
Government (5275)
Grass and pollen (7)
Guidances (191)
Healthcare (20919)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (189)
Immuno-oncology (13)
Indications (42)
Infectious disease (3115)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (76)
Intellectual property (127)
Interviews (813)
IPO (17907)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (59)
Layoffs (598)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (443)
Lymphoma (221)
Machine learning (12)
Management (65)
Manufacturing (467)
MASH (101)
Medical device (14744)
Medtech (14750)
Mergers & acquisitions (22599)
Metabolic disorders (974)
Multiple sclerosis (106)
NASH (23)
Neurodegenerative disease (155)
Neuropsychiatric disorders (46)
Neuroscience (2373)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (50)
Obesity (497)
Opinion (291)
Ovarian cancer (105)
Pain (125)
Pancreatic cancer (131)
Parkinson's disease (203)
Partnered (25)
Patents (327)
Patient recruitment (181)
Peanut (55)
People (65777)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22961)
Phase II (32315)
Phase III (24338)
Pipeline (1750)
Policy (247)
Postmarket research (3553)
Preclinical (10372)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (536)
Real estate (7402)
Recruiting (76)
Regulatory (27279)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (101)
Series A (174)
Series B (119)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4306)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (68)
The Weekly (95)
Vaccines (931)
Venture capital (59)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (79)
Last 7 days (524)
Last 30 days (1765)
Last 365 days (33948)
2025 (19244)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (71)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50577)
Australia (8884)
California (7940)
Canada (2455)
China (737)
Colorado (341)
Connecticut (353)
Delaware (211)
Europe (116061)
Florida (1178)
Georgia (271)
Hawaii (3)
Idaho (67)
Illinois (752)
India (33)
Indiana (393)
Iowa (19)
Japan (242)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1119)
Massachusetts (6077)
Michigan (278)
Minnesota (496)
Mississippi (3)
Missouri (106)
Montana (32)
Nebraska (26)
Nevada (86)
New Hampshire (74)
New Jersey (2230)
New Mexico (31)
New York (2219)
North Carolina (1258)
North Dakota (10)
Northern California (3439)
Ohio (256)
Oklahoma (17)
Oregon (48)
Pennsylvania (1699)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2947)
Tennessee (130)
Texas (1220)
United States (29947)
Utah (231)
Virginia (218)
Washington D.C. (80)
Washington State (699)
West Virginia (4)
Wisconsin (87)
There are 853,705 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abivax Announces Closing of $747.5 Million Public Offering
July 29, 2025
·
9 min read
Press Releases
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
July 29, 2025
·
7 min read
Press Releases
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
July 29, 2025
·
12 min read
Press Releases
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
July 29, 2025
·
38 min read
Press Releases
Delay in CE Approval for XVIVO’s Perfusion Solution for Heart Preservation
July 29, 2025
·
3 min read
Press Releases
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
July 29, 2025
·
4 min read
Press Releases
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
July 29, 2025
·
6 min read
Press Releases
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
July 29, 2025
·
14 min read
Press Releases
Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer
July 29, 2025
·
3 min read
Press Releases
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
July 29, 2025
·
2 min read
1 of 85,371
Next
